These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2677177)

  • 21. The promise of colony-stimulating factors in clinical practice.
    Glaspy JA; Ambersley JM
    Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of growth factors in cancer treatment].
    Ogawa M
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1227-31. PubMed ID: 1711305
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceleration of autologous hematopoietic recovery by GM-CSF after allograft rejection.
    Bandini G; Rosti G; Cavo M; Albertazzi L; Tura S
    Haematologica; 1989; 74(6):627-8. PubMed ID: 2697676
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical use of GM-CSF in autologous bone marrow transplantation.
    Carella AM; Gaozza E; Piatti G; Giordano D; Santini G; Carlier P; Raffo MR; Nati AS; Congin A; Bacigalupo A
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():279-82. PubMed ID: 2182740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [GM-CSF: its use in onco-hematologic diseases].
    Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
    Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
    [No Abstract]   [Full Text] [Related]  

  • 27. Perspectives in the prevention and treatment of acute graft versus host disease.
    Herve P
    Bone Marrow Transplant; 1991; 7 Suppl 2():117-9. PubMed ID: 1715225
    [No Abstract]   [Full Text] [Related]  

  • 28. GM-CSF may hasten patient recovery while reducing costs.
    Oncology (Williston Park); 1989 Jul; 3(7):56, 59. PubMed ID: 2701812
    [No Abstract]   [Full Text] [Related]  

  • 29. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
    Sallerfors B; Olofsson T; Lenhoff S
    Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [GM-CSF: its clinical administration; the treatment of aplasia].
    Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
    Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
    [No Abstract]   [Full Text] [Related]  

  • 32. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
    Nissen-Druey C
    Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of a marrow stem-cell disorder with granulocyte colony-stimulating factor.
    Quesenberry PJ
    N Engl J Med; 1989 May; 320(20):1343-5. PubMed ID: 2469957
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
    Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
    N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
    Klingemann HG; Eaves AC; Barnett MJ; Reece DE; Shepherd JD; Belch AR; Brandwein JM; Langleben A; Koch PA; Phillips GL
    Clin Invest Med; 1990 Apr; 13(2):77-81. PubMed ID: 2191816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemopoietic growth factors: a review.
    Morstyn G; Burgess AW
    Cancer Res; 1988 Oct; 48(20):5624-37. PubMed ID: 2458827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic growth factors in marrow transplantation and radiation injury.
    Storb R; Appelbaum F; Nemunaitis J; Schuening F; Singer J; Epstein C; Buckner CD; Souza LM; Thomas ED
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():116-20. PubMed ID: 1697190
    [No Abstract]   [Full Text] [Related]  

  • 38. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.
    Shadduck RK; Rosenfeld CS; Sulecki M; Phillips N; Przepiorka D; Earle M; Stoller R; Jacobs S
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():303-12; discussion 312-3. PubMed ID: 2182742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of GM-CSF in bone marrow transplantation.
    Vose JM; Armitage JO
    Behring Inst Mitt; 1991 Dec; (90):39-43. PubMed ID: 1801689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.